|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Clovis Oncology, Inc. (CLVS) |
|
|
$0.02 0.00 (0.00%) as of 4:30 Mon 7/10
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
88,200,000 |
| Market
Cap: |
1.32(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0103 - $0.042 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
79,699 |
| Total Sell Value |
$0 |
$0 |
$0 |
$104,765 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rolfe Lindsey |
See Remarks |
• – – |
2021-03-02 |
4 |
S |
$6.29 |
$4,158 |
D/D |
(661) |
69,364 |
|
7% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
19 |
3,118 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
540 |
7,523 |
|
- |
|
| Muehl Daniel W |
See Remarks |
• – – |
2021-03-01 |
4 |
S |
$6.29 |
$2,868 |
D/D |
(456) |
47,566 |
|
13% |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,313 |
245,383 |
|
- |
|
| Gross Paul Edward |
See Remarks |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,032 |
43,770 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,313 |
69,710 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$8.17 |
$6,961 |
I/I |
(852) |
3,099 |
|
29% |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$94,150 |
D/D |
(11,813) |
68,712 |
|
29% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$41,827 |
D/D |
(5,248) |
7,126 |
|
29% |
|
| Gross Paul Edward |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$94,628 |
D/D |
(11,873) |
42,945 |
|
29% |
|
| Muehl Daniel W |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$94,620 |
D/D |
(11,872) |
46,990 |
|
29% |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2021-02-02 |
4 |
S |
$7.97 |
$87,590 |
D/D |
(10,990) |
244,346 |
|
29% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,975 |
3,412 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,250 |
78,534 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,813 |
11,443 |
|
- |
|
| Gross Paul Edward |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,125 |
52,200 |
|
- |
|
| Muehl Daniel W |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,125 |
56,244 |
|
- |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,250 |
253,377 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2020-12-21 |
4 |
S |
$5.68 |
$9,815 |
D/D |
(1,728) |
58,275 |
|
-10% |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2020-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
60,003 |
|
- |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2020-12-21 |
4 |
S |
$5.68 |
$4,709 |
D/D |
(829) |
233,086 |
|
-10% |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2020-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
233,915 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2020-12-15 |
4 |
D |
$5.11 |
$72,322 |
D/D |
(14,153) |
56,565 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2020-12-15 |
4 |
OE |
$3.28 |
$56,550 |
D/D |
17,241 |
70,718 |
|
- |
|
509 Records found
|
|
Page 8 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
